Skip to Content

Correction

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Asporogenic B. ANTHRACIS Expression System

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 34519 End Preamble Start Supplemental Information

Correction

In notice document 02-11067 beginning on page 22412 in the issue of Friday, May 3, 2002 make the following correction:

On page 22413, in the first column, under “ADDRESSES:” in the fifth line, “21705-5012” should read “21702-5012”.

End Supplemental Information Start Preamble End Preamble Start Supplemental Information

Correction

In notice document 02-11073 appearing on page 22413 in the issue of Friday, May 3, 2002 make the following correction:

On page 22413, in the third column, under “FOR FURTHER INFORMATION CONTACT:”, in the fifth line, in the phone number “(508) 233-4298-4298” delete the duplicate “-4298”.

End Supplemental Information Start Preamble End Preamble Start Supplemental Information

Correction

In notice document 02-11070 beginning on page 22413 in the issue of Friday, May 3, 2002 make the following corrections:

1. On page 22414, in the first column, under “ADDRESSES:”, in the sixth line, “ 21705-5012” should read “21702-5012”.

2. On the same page, in the same column, under “SUPPLEMENTARY INFORMATION:”, in the fourth line, after the word “system” insert the word “can”.

End Supplemental Information

[FR Doc. C2-11067 Filed 5-13-02; 8:45 am]

BILLING CODE 1505-01-D

[FR Doc. C2-11073 Filed 5-13-02; 8:45 am]

BILLING CODE 1505-01-D

[FR Doc. C2-11070 Filed 5-13-02; 8:45 am]

BILLING CODE 1505-01-D